IR Biosciences Holdings, Inc. Share Price
Equities
IRBS
US46264M3034
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
Sales 2009 | - | Sales 2010 | - | Capitalization | 1.2M 99.79M |
---|---|---|---|---|---|
Net income 2009 | -6M -501M | Net income 2010 | -5M -417M | EV / Sales 2009 | - |
Net Debt 2009 | 5.81M 485M | Net Debt 2010 | 3.67M 306M | EV / Sales 2010 | - |
P/E ratio 2009 |
-0.37
x | P/E ratio 2010 |
-0.2
x | Employees | 4 |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 01/03/01 | |
John N. Fermanis
DFI | Director of Finance/CFO | 70 | 01/04/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 01/03/01 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 17 | |
+1.51% | 42.75B | |
+48.49% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- IRBS Stock